FDA

News
|

Is lack of standardized medical device labeling harming patients?

The FDA is studying if they should require standardized medical device labeling.
E-Book Special Report
Total Cost of Ownership
Sign up to receive timely updates from our editors and download this E-Book Special Report to learn how to calculate the true Total Cost of Ownership (TCO) of your packaging machinery.
News
|

Near record lows for medical device recalls

It's been two years since the FDA saw recall numbers this low.
FDA issues final guidance on the evaluation and labeling of abuse-deterrent opioids
News
|

FDA issues final guidance on the evaluation and labeling of abuse-deterrent opioids

The U.S. Food and Drug Administration on April 1, 2015 issued a final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties.
Syringes
Feature Article
|

Pharmapack Europe covered lots of ground

Exclusive coverage fom Pharmapack Europe includes strategies for handling injectables, updates on new regs for med devices, and a look at the challenges of veterinary drugs.
News
|

FDA issues guidance for repackaging

The U.S. Food and Drug Administration issued a Feb. 2015 Guidance for Industry titled, “Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities,” that is being distributed for comment purposes only.
Eric Greenberg
Column/Opinion
|

Regulators have a range of approaches

What is the best way for a state to assure that people drive safely?
Afrezza (insulin human) Inhalation Powder
Package Case Study
|

Sanofi launches Afrezza inhalable insulin for diabetes treatment

Global healthcare company Sanofi and biopharma-ceutical company MannKind Corp. announced that Afrezza (insulin human) Inhalation Powder is now available by prescription in U.S. retail pharmacies nationwide.
Global Data forecast sees significant U.S. pharmaceutical market growth
News
|

Forecast sees significant U.S. pharmaceutical market growth

The Patient Protection and Affordable Care Act, faster FDA product approvals, and millions of previously uninsured people potentially entering the patient pool expected to help drive future pharmaceutical growth.
Eric Greenberg
Column/Opinion
|

Sunscreens: follow FDA specs or get burned

You know what’s great about modern healthcare?
Drug compounding
News
|

FDA issues guidance for outsourcing facilities

On Nov. 21, 2014, the U.S. Food and Drug Administration issued three additional policy documents to assist entities that compound sterile human drugs with registering as outsourcing facilities.

Pages

Subscribe to FDA

Newsletters

Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
PACKAGING MACHINERY
SPECIAL INTEREST
PACK EXPO
Each newsletter ranges in frequency from once per month to a few times per month at most.